SEIKAGAKU CORPORATION
Live / Registered — Registered — Section 71 accepted (as of 01 May 2024)
What this means for you
Registered since 10 Sept 2013. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79071477
- Registration number
- 4398169
- Mark type
- Stylized text
- Filed
- 13 Mar 2009
- Published for opposition
- 25 Jun 2013
- Registered
- 10 Sept 2013
- Attorney of record
- Mainak H. Mehta
Goods and services
- Class 001 — Chemicals: [ Hyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, and for research purposes in the biomedical field; ] Chondroitin sulfate and salts of chondoroitin sulfate as raw materials for use in the production of pharmaceutical preparations, [ cosmetic preparations, food, nutritional supplements and ] biomaterials, and for research purposes in the biomedical field; Chemical reagents for scientific, research and quality control purposes, namely, limulus amebocyte lysate reagents for use in analysis of endotoxins [ and beta-glucan ] ; Reagents for scientific medical research and quality control testing use, namely, for use in determining the presence of analytes in or on water, pharmaceutical products, medical devices, dialysate, blood, blood components, body fluids, and tissues; Reagents for clinical or medical laboratory use, namely, glycobiological analysis reagents and diagnostic preparations and reagents for clinical or medical laboratory use
- Class 005 — Pharmaceuticals: Joint function improving agents, namely, pharmaceutical preparations for treating arthrosis and other joint diseases; [ ophthalmic surgical aid, namely, sodium hyaluronate solution used for surgery in and around the eyes; Submucosal injection materials for endoscopes used for the treatment of dissecting and resecting tumors and cancer, namely, submucosal injectable preparations for treatment of dissecting and resecting tumors and cancer; Pharmaceutical preparations for the treatment of disc hernia; ] Syringes sold filled with crosslinked or non-crosslinked hyaluronic acid based gel; Syringes sold filled with sodium hyaluronate solutions [ ; Diagnostic preparations for medical purposes for detecting mycosis; Diagnostic preparations for medical purposes, namely, diagnostic reagents for in-vitro clinical diagnostic purposes ]
- Class 010 — Medical apparatus: [ Injection syringes; Injection needles; Ophthalmic and intra-articular applicators for pharmaceutical preparations ]
Owner
- SEIKAGAKU CORPORATION, Tokyo, JP
- SEIKAGAKU CORPORATION, JP
- SEIKAGAKU CORPORATION, JP
Prosecution history
- 15 Mar 2025 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 02 Jan 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 01 May 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 01 May 2024 — REGISTERED-SEC.71 ACCEPTED
- 23 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Aug 2023 — TEAS SECTION 71 RECEIVED
- 10 Sept 2022 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 25 Dec 2021 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 14 Nov 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 14 Nov 2021 — INVALIDATION PROCESSED
- 24 Oct 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 24 Feb 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 24 Feb 2021 — REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
- 17 Feb 2021 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 05 Dec 2020 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE